Farmak intends exports to Malaysian market by late 2018
Ukrainian pharmaceutical company Farmak plans to register its products in Malaysia by late 2018, Farmak Business Development Director Oleh Siarkevych has told Interfax-Ukraine.
He said that first the company intends to bring its strategic products to new markets, in particular, insulin and Amizonum created by the company.
In addition, the company plans to offer its ophthalmological portfolio to the Malaysian market, as well as contrast medium.
As reported, as part of the official visit of Poroshenko to Malaysia the Ukrainian-Malaysian Busines Forum was held early August. Ukrainian pharmaceutical manufacturers took part.
Advertising
Advertising
MORE ABOUT
Ukrainian pharma manufacturers lose 3-5% of revenues due to state regulation – expert
11:10, 18.11.2025
Number of new residential complexes for sale in capital region up by 70% - LUN
20:08, 12.11.2025
Number of insurers, banks in Ukraine unchanged in Sept
19:24, 14.10.2025
Passenger EV segment in Ukraine up 90% in Sept, share of new cars rises to 17%
20:04, 07.10.2025
Ukrainian Parliament's economic committee proposes separate exchange trading system for small wood processors
20:38, 26.09.2025
LATEST
Ukraine's State Agency revises claims about UAH 6.6 bln road through Bukovel
20:30, 05.12.2025
G7, EU countries considering complete ban on oil transportation from Russia instead of price cap – media
20:29, 05.12.2025
Intl support for humanitarian demining since 2022 reaches nearly $1.5 bln – Economy Minister
19:42, 05.12.2025
Eighty-three candidates apply for four Energoatom Supervisory Board seats
14:02, 05.12.2025
Vodafone Ukraine announces another buy-out of eurobonds for $1.16 mln